Beta-blocker Discontinuation in Heart Failure With Preserved Ejection Fraction
Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-80
SponsorUConn Health
About this trial
This is a prospective pilot study to evaluate changes before and 4 weeks after beta-blocker withdrawal in 30 HFpEF patients.
Eligibility criteria
Qualifiers
Stable HFpEF patients with NYHA Class II-III or elevated BNP ≥100
N=30 (Target: 30).
Age: 50 ~ 80 years.
ECHO evidence of EF ≥50% and Grade 2 or 3 diastolic dysfunction.
Disqualifiers
Beta blocker was prescribed for treating other cardiac conditions such as atrial fibrillation or coronary artery disease.
Heart rate > 100 bpm
Recent hospitalization due to HF within 3 months
Non-English speaker
Trial design
Treatments tested in this trial
- beta blocker discontinuation
Treatment groups
30 Participants
are divided into 1 treatment groupSponsors and collaborators
Source ClinicalTrials.gov